Here is a job opportunity for those who qualify.
Up until the birth of the EtG, tests used for forensic drug and alcohol monitoring had to go through the arduous, expensive and necessary FDA approval process. The LDT pathway was designed to develop simple tests with little risk that have low market potential (i;e. the cost of the normal FDA approval process would prohibit them from coming to market). The LDT pathway was designed to improve patient care in the diagnosis and treatment of patients. It was not designed for forensic tests. LDT approval does not require in vivo testing. It is essentially an honor system and to develop an LDT it is not even necessary to prove that the test is actually testing what it is purportedly testing for (validity).
So with little to no evidence base an ASAM/FSPHP physician introduced the…
View original post 88 more words
- “Support the education of physicians and the public regarding the importance of psychosocial and spiritual interventions for the treatment of all persons with substance use disorders.
- Encourage the judicious use of Twelve Step recovery modalities for the treatment of substance use disorders.
- Encourage ABAM Fellowship training programs to require sufficient experience in the use of psychosocial, spiritual and Twelve Step interventions and to include test questions to discern a Fellows knowledge base regarding these aspects.
- Continue to provide presentations that support the philosophy of “Like Minded Docs” to ASAM, treatment providers, public, judicial and political arenas.
- Support the current ASAM Twelve Step Action Group.
- Support all activities that raise the consciousness regarding the importance of psychosocial and spiritual interventions.
- Promote further studies into the biological, social, psychological and spiritual aspects of recovery.
- Maintain the “high road” and not disparage alternative forms of treatment, but rather to promote those aspects…
View original post 145 more words